Looking Ahead: The Future of Chronic GVHD Management and Patient Care

Opinion
Video

Panelists conclude by discussing the future of graft-versus-host disease management, expressing their hopes for the current treatment landscape and potential advancements that could further improve patient outcomes and quality of life.

Video content above is prompted by the following:

Can you tell us about axatilimab and its potential role in cGVHD treatment? How does its mechanism of action differ from other therapies? Please briefly highlight the AGAVE-201 trial and data.

Recent Videos
Related Content